Skip to content
Recall Observatory FDA recall evidence

Drug product

Buprenorphine HCl, CIII, Injection, 0.3 mg/mL, 5 x 1 mL Single Dose Vials per Carton, Rx Only, For Intramuscular or Intravenous use, Manufactured for: Endo USA, Malvern, PA 19355, NDC 42023-179-05

D-0596-2026

June 12, 2026

Class II

Product summary

Firm
Par Health USA, LLC
Event
Event 99237
Status
Ongoing
Classification
Class II
Quantity
46,334 units
Official record key
drug-enforcement:D-0596-2026

Official wording

Reason: Crystallization; identified as Buprenorphine free base

Code information: Lot #: 82886, exp 09/30/2026; 89646, exp 05/31/2027

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Crystallization; identified as Buprenorphine free base